Clinical experience with dalbavancin for the treatment of deep sternal wound infection
CONCLUSIONDalbavancin may be an alternative option for DSWI caused by gram-positive bacteria when first line treatments are contraindicated or as a salvage treatment.
Source: Journal of Global Antimicrobial Resistance - Category: Infectious Diseases Source Type: research
More News: Antimicrobial Resistance | Candida | Cardiology | Heart | Infectious Diseases | Italy Health | MRSA | Staphylococcus Aureus | Study | Superbugs